Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

University Develops First Diagnostic Blood Test for Parkinson's

April 22, 2016 11:04 am | by Greg Watry, Digital Reporter | Articles | Comments

The university reported the test has undergone trials with 38 people, 29 with Parkinson’s and nine without.

TOPICS:

New Genetic Risk Factors for Myopia Discovered

April 22, 2016 10:59 am | by Johannes Gutenberg Universitaet Manz | News | Comments

Genes and environment determine short-sightedness.

TOPICS:

Novartis Profits Dip as Generic Rival Challenges Cancer Drug

April 22, 2016 10:59 am | by The Associated Press | News | Comments

Shares of Novartis were down 0.7 percent at 74.55 Swiss francs in mid-morning trading on the Six Swiss stock exchange.

TOPICS:
Advertisement

Global Viral Infections Market to Reach $117.6B by 2021

April 22, 2016 10:58 am | by Fiona Chisholm, Analyst, GBI Research | Articles | Comments

The availability of generic drugs is expected to increase due to a series of recent and upcoming patent expirations for key marketed products, particularly within HIV.

TOPICS:

Obesity Is Now Linked to 11 Types of Cancer

April 22, 2016 10:57 am | by Laura Lorenzetti, Fortune | News | Comments

Alcohol and bacon are some of the key culprits.

TOPICS:

Researchers Discover New Pathway That May Trigger Asthma

April 21, 2016 2:56 pm | by University of Pennsylvania | News | Comments

Asthma is a chronic condition that affects more than 25 million people in the United States alone. 

TOPICS:

AbbVie Inks Collaboration with Argenx to Develop Novel Immuno-oncology Target

April 21, 2016 12:44 pm | News | Comments

Under the terms of the agreement, argenx will conduct research and development through IND-enabling studies.

TOPICS:

Novartis’ Muscle Disease Drug Misses Goal in Late-Stage Trial

April 21, 2016 12:13 pm | by Ryan Bushey, Digital Editor | News | Comments

Novartis published their first quarter financial report, which included information on bimagrumab, a drug developed in conjunction with Morphosys to treat a muscle-wasting disease called sporadic inclusion body myositis (sIBM).

TOPICS:
Advertisement

Orphan Status Granted to GW's Cannabis Drug

April 21, 2016 10:23 am | by Ryan Bushey, Digital Editor | Articles | Comments

This disease marks the third treatment indication GW is pursuing.

TOPICS:

Study Finds Explanation for Some Treatment-Resistant Breast Cancers

April 21, 2016 9:45 am | by Vanderbilt University Medical Center | News | Comments

A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.

TOPICS:

Risperidone: Increased Appetite, Weight Gain in Children Treated for Autism

April 21, 2016 9:32 am | by Emory University | News | Comments

The drug risperidone has been successful in reducing serious behavioral problems in children with autism spectrum disorder (ASD), but researchers have discovered that increased appetite, followed by weight gain, can be a undesirable adverse effect. 

TOPICS:

Cancer Survival Rates Could Increase with Aspirin Regimen

April 21, 2016 8:34 am | by Cardiff University | News | Comments

The team’s review looked at all of the available data including five randomized trials and forty two observational studies of colorectal, breast and prostate cancers.

TOPICS:

Research Could Expand Engineered T-Cell Cancer Treatment

April 21, 2016 8:30 am | by Purdue University | News | Comments

T cells are the immune system's natural defense against cancer and other harmful entities in the human body. 

TOPICS:

Biden Urges Cancer Researchers to Collaborate, Calls for Guidance

April 20, 2016 4:39 pm | by Stephanie Guzowski, Editor | Articles | Comments

Vice President Joe Biden encouraged the nation’s leading cancer researchers to collaborate more effectively and to share data in an effort to accelerate ambitious cancer research goals, at the American Association for Cancer Research annual meeting.

TOPICS:

Targeted Agent to Mitigate Sepsis

April 20, 2016 3:14 pm | by Institute for Basic Science | News | Comments

Sepsis is caused by the immune system severely overreacting to an infection and attacking itself.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading